12/21/2018, 5:55 PM (Source: TeleTrader)
more TeleTrader news

Novartis completes $2.1B purchase of Endocyte

Pharmaceutical giant Novartis AG announced on Friday it completed the acquisition of American biopharmaceutical firm Endocyte, Inc.

The Switzerland-based company noted that with the purchase of Endocyte, which specializes in cancer treatment by developing radioligand and CAR-T therapies, it will strengthen its position in the fields of nuclear medicine and radioligand therapy.

Novartis first announced its $2.1 billion deal to buy Endocyte in October.

Breaking the News / NP